Glucagon Market size was valued at USD 0.95 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030.
Discover Region-Wise Trends in the Glucagon Market: Insights and Impacts
The glucagon market is witnessing significant growth, driven by rising diabetes cases and advancements in diabetes management. This peptide hormone plays a crucial role in glucose metabolism, highlighting its importance in therapeutic treatments.
North America dominates the glucagon market, holding approximately 40% of the global share. This is primarily attributed to:
High prevalence of diabetes and obesity.
Advanced healthcare infrastructure.
Robust research and development in biopharmaceuticals.
The FDA's approval of new glucagon formulations further aids this region's growth.
Europe is experiencing steady growth in the glucagon market, with an expected CAGR of 5.8% from 2023-2030. Factors contributing include:
Growing awareness of diabetes management.
Increased investments in health technology.
Countries like Germany and the UK are at the forefront, with active participation in clinical trials.
The Asia-Pacific region showcases the fastest growth rate, projected to increase by 7.5% annually. Key elements include:
Rapid urbanization and lifestyle changes.
Growing healthcare expenditure.
Government initiatives for diabetes awareness.
China and India are major contributors, leveraging their vast population base and increasing healthcare access.
The glucagon market in the Middle East and Africa is still nascent but is on a growth trajectory. Challenges such as healthcare access are being addressed by:
International collaborations.
Innovative funding models to improve drug accessibility.
As diabetes rates rise, the focus on glucagon treatment will intensify.
Several trends are influencing the glucagon market globally:
Shift towards personalized medicine.
Technological advancements in glucagon delivery systems.
Increasing collaborations between biotech companies and pharma giants.
Understanding these trends is crucial for stakeholders aiming to capitalize on market potential.
</>
Â
Download Full PDF Sample Copy of Automotive End-Point Authentication Market Report @ https://www.verifiedmarketreports.com/download-sample/?rid=126422&utm_source=Sites-google&utm_medium=289
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Novo Nordisk
Segmentation analysis involves dividing the market into distinct groups based on certain criteria, such as type and application. This helps in understanding the market dynamics, targeting specific customer groups, and devising tailored marketing strategies.
Â
Inject Glucagon
Nasal Glucagon
Â
Â
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Â
North America (United States, North America and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Get a Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=126422&utm_source=Sites-google&utm_medium=289
1. Introduction of the Glucagon Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Glucagon Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Glucagon Market , By Product
6. Glucagon Market , By Application
7. Glucagon Market , By Geography
North America
Europe
Asia Pacific
Rest of the World
8. Glucagon Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
For More Information or Query, visit @ https://www.verifiedmarketreports.com/product/global-glucagon-market-report-2019-competitive-landscape-trends-and-opportunities/
Glucagon is a hormone that raises the level of glucose (sugar) in the blood.
The increasing prevalence of diabetes and the rising demand for emergency kits for severe hypoglycemia are driving the glucagon market.
The global glucagon market was valued at $500 million in 2019 and is projected to reach $700 million by 2026.
The glucagon market offers injectable glucagon emergency kits and nasal glucagon products.
The key players in the glucagon market include Novo Nordisk, Zealand Pharma, and Eli Lilly and Company.
Injectable glucagon emergency kits hold the majority market share, accounting for over 70% of the glucagon market.
The glucagon market is expected to grow at a CAGR of 6.5% from 2020 to 2025.
The glucagon market is segmented by product type, application, and region.
The high cost of glucagon emergency kits and the lack of awareness about severe hypoglycemia are the key challenges for the glucagon market.
The Asia-Pacific region offers significant opportunities for the glucagon market due to the rising diabetes prevalence and increasing healthcare expenditure.
Intense competition among market players is leading to product innovation, strategic partnerships, and mergers and acquisitions in the glucagon market.
Glucagon products are regulated by the FDA in the United States and by the EMA in the European Union.
Nasal glucagon products have a relatively lower market penetration compared to injectable glucagon emergency kits, but are expected to gain traction in the coming years.
Pricing in the glucagon market is influenced by factors such as product features, brand reputation, and competition.
The key growth strategies include product development, geographical expansion, and focus on R&D investments.
Reimbursement for glucagon products varies by region and healthcare coverage, impacting market adoption and sales.
Some emerging trends in the glucagon market include the development of stable room-temperature glucagon formulations and the use of digital health solutions for diabetes management.
The COVID-19 pandemic has led to disruptions in the supply chain and a temporary decline in glucagon market growth due to reduced healthcare visits and elective procedures.
The increasing prevalence of diabetes in children and the need for safe and effective glucagon options present a significant market potential in the pediatric population.
The glucagon market is expected to witness continued growth driven by technological advancements, increasing diabetes prevalence, and expanding healthcare infrastructure in developing economies.
</>
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies.
We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Tributyl O-acetylcitrate (CAS 77-90-7) Market
Enameled Copper Flat Wire Market
Emulsifiers in Baked Goods Market